A detailed history of Briaud Financial Planning, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Briaud Financial Planning, Inc holds 146 shares of LLY stock, worth $109,209. This represents 0.07% of its overall portfolio holdings.

Number of Shares
146
Previous 146 -0.0%
Holding current value
$109,209
Previous $132,000 2.27%
% of portfolio
0.07%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $86,461 - $115,672
146 New
146 $114,000
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $63,466 - $87,497
146 New
146 $78,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Briaud Financial Planning, Inc Portfolio

Follow Briaud Financial Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Briaud Financial Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Briaud Financial Planning, Inc with notifications on news.